{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:57:42Z","timestamp":1790035062784,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11096-019-00832-4","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T04:05:06Z","timestamp":1556856306000},"page":"880-887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Characteristic of drug-related problems and pharmacists\u2019 interventions in a stroke unit in Thailand"],"prefix":"10.1007","volume":"41","author":[{"given":"Kannikar","family":"Semcharoen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajja","family":"Supornpun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surakit","family":"Nathisuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junporn","family":"Kongwatcharapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"key":"832_CR1","first-page":"26","volume-title":"To err is human: building a safer health system","author":"Institute of Medicine Committee on Quality of Health Care in America","year":"2000","unstructured":"Institute of Medicine Committee on Quality of Health Care in America. Errors in health care: a leading cause of death and injury. In: Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Washington, DC: National Academies Press; 2000. p. 26\u201348."},{"issue":"11","key":"832_CR2","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/pds.3309","volume":"21","author":"A Miguel","year":"2012","unstructured":"Miguel A, Azevedo LF, Araujo M, Pereira AC. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2012;21(11):1139\u201354.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"832_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/qshc.2007.023622","volume":"17","author":"EN de Vries","year":"2008","unstructured":"de Vries EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care. 2008;17(3):216\u201323.","journal-title":"Qual Saf Health Care"},{"issue":"4","key":"832_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1001\/jama.1997.03540280045032","volume":"277","author":"DW Bates","year":"1997","unstructured":"Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. J Am Med Assoc. 1997;277(4):307\u201311.","journal-title":"J Am Med Assoc."},{"issue":"3","key":"832_CR5","first-page":"533","volume":"47","author":"CD Hepler","year":"1990","unstructured":"Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533\u201343.","journal-title":"Am J Hosp Pharm"},{"issue":"3","key":"832_CR6","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.282.3.267","volume":"282","author":"LL Leape","year":"1999","unstructured":"Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. J Am Med Assoc. 1999;282(3):267\u201370.","journal-title":"J Am Med Assoc"},{"issue":"9","key":"832_CR7","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/archinte.166.9.955","volume":"166","author":"PJ Kaboli","year":"2006","unstructured":"Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955\u201364.","journal-title":"Arch Intern Med"},{"issue":"17","key":"832_CR8","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1001\/archinte.163.17.2014","volume":"163","author":"SN Kucukarslan","year":"2003","unstructured":"Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163(17):2014\u20138.","journal-title":"Arch Intern Med"},{"issue":"4","key":"832_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1046\/j.1365-2125.2003.02029.x","volume":"57","author":"MJ Dooley","year":"2004","unstructured":"Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004;57(4):513\u201321.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"832_CR10","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.18295\/squmj.2018.18.01.013","volume":"18","author":"VA Sagita","year":"2018","unstructured":"Sagita VA, Bahtiar A, Andrajati R. Evaluation of a clinical pharmacist intervention on clinical and drug-related problems among coronary heart disease inpatients: a pre-experimental prospective study at a general hospital in Indonesia. Sultan Qaboos Univ Med J. 2018;18(1):e81\u20137.","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"12","key":"832_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jgs.13807","volume":"63","author":"JT Hanlon","year":"2015","unstructured":"Hanlon JT, Semla TP, Schmader KE. Alternative Medications for medications in the use of high-risk medications in the elderly and potentially harmful drug-disease interactions in the elderly quality measures. J Am Geriatr Soc. 2015;63(12):1\u201311.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"832_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4103\/2279-042X.185750","volume":"5","author":"VS Kanagala","year":"2016","unstructured":"Kanagala VS, Anusha A, Rao BS, Challa SR, Nalla KS, Gadde RS. A study of medication-related problems in stroke patients: a need for pharmaceutical care. J Res Pharm Pract. 2016;5(3):222\u20135.","journal-title":"J Res Pharm Pract"},{"issue":"4","key":"832_CR13","first-page":"28","volume":"5","author":"A Celin","year":"2012","unstructured":"Celin A, Seuma J, Ramesh A. Assessment of drug related problems in stroke patients admitted to a South Indian tertiary care teaching hospital. Indian J Pharm Pract. 2012;5(4):28\u201333.","journal-title":"Indian J Pharm Pract"},{"issue":"6","key":"832_CR14","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s11096-012-9690-7","volume":"34","author":"C Hohmann","year":"2012","unstructured":"Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Drug-related problems in patients with ischemic stroke in hospital. Int J Clin Pharm. 2012;34(6):828\u201331.","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"832_CR15","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2018;49(3):e46\u2013110.","journal-title":"Stroke"},{"key":"832_CR16","isbn-type":"print","volume-title":"Biostatistics: a foundation for analysis in the health sciences","author":"WW Daniel","year":"2013","unstructured":"Daniel WW, Cross CL. Biostatistics: a foundation for analysis in the health sciences. Hoboken: Wiley; 2013. ISBN: 978-1-118-30279-8.","ISBN":"https:\/\/id.crossref.org\/isbn\/9781118302798"},{"issue":"4","key":"832_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s11096-006-9027-5","volume":"28","author":"B Allenet","year":"2006","unstructured":"Allenet B, Bedouch P, Rose FX, Escofier L, Roubille R, Charpiat B. Validation of an instrument for the documentation of clinical pharmacists\u2019 interventions. Pharm World Sci. 2006;28(4):181\u20138.","journal-title":"Pharm World Sci"},{"key":"832_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2147\/IJGM.S109104","volume":"9","author":"JS Habert","year":"2016","unstructured":"Habert JS. Minimizing bleeding risk in patients receiving direct oral anticoagulants for stroke prevention. Int J Gen Med. 2016;9:337\u201347.","journal-title":"Int J Gen Med"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00832-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-019-00832-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00832-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T23:20:07Z","timestamp":1588375207000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-019-00832-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1007\/s11096-019-00832-4","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]},"assertion":[{"value":"9 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No specific funding was provided for the completion of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All authors declare that they have no conflict of interest either personally or financially.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}